学术探索
学术期刊
新闻热点
数据分析
智能评审

An extremely different dysmetabolic profile between the two available nonnucleoside reverse transcriptase inhibitors: Efavirenz and nevirapine

被引：27
作者：
Manfredi, R [1 ]
Calza, L [1 ]
Chiodo, F [1 ]
机构：
[1] Univ Bologna, Dept Clin & Expt Med, Div Infect Dis, S Orsola M Malpighi Hosp,Alma Mater Studiorum, Bologna, Italy
来源：
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2005年 / 38卷 / 02期
关键词：
D O I：
10.1097/01.qai.0000143037.70120.fc
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：236 / 238
页数：3
相关论文
共 9 条
  • [1] Chiesa E, 2003, ANTIVIR THER, V8, P27
  • [2] Impact of various antiretroviral drugs and their plasma concentrations on plasma lipids in heavily pretreated HIV-infected patients
    Clevenbergh, P
    Garraffo, R
    Dellamonica, P
    [J]. HIV CLINICAL TRIALS, 2003, 4 (05): : 330 - 336
  • [3] Virologic and immunologic response to regimens containing nevirapine or efavirenz in combination with 2 nucleoside analogues in the Italian Cohort Naive Antiretrovirals (I.Co.NA) study
    Cozzi-Lepri, A
    Phillips, AN
    Monforte, AD
    Piersantelli, N
    Orani, A
    Petrosillo, N
    Leoncini, F
    Scerbo, A
    Tundo, P
    Abrescia, N
    Moroni, M
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (08) : 1062 - 1069
  • [4] A comparison of the effects of nevirapine and nelfinavir on metabolism and body habitus in antiretroviral-naive human immunodeficiency virus-infected patients: A randomized controlled study
    Fisac, C
    Virgili, N
    Ferrer, E
    Barbera, MJ
    Fumero, E
    Vilarasau, C
    Podzamczer, D
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (11) : 5186 - 5192
  • [5] Cardiovascular disease risk factors in HIV patients -: association with antiretroviral therapy.: Results from the DAD study
    Friis-Moller, N
    Weber, R
    Reiss, P
    Thiébaut, R
    Kirk, O
    Monforte, AD
    Pradier, C
    Morfeldt, L
    Mateu, S
    Law, M
    El-Sadr, W
    De Wit, S
    Sabin, CA
    Phillips, AN
    Lundgren, JD
    [J]. AIDS, 2003, 17 (08) : 1179 - 1193
  • [6] HADRI KE, 2004, J BIOL CHEM, V279, P15130
  • [7] Keiser Philip, 2002, HIV Clin Trials, V3, P296
  • [8] Reversal of atherogenic lipoprotein profile in HIV-1 infected patients with lipodystrophy after replacing protease inhibitors by nevirapine
    Negredo, E
    Ribalta, J
    Paredes, R
    Ferré, R
    Sirera, G
    Ruiz, L
    Salazar, J
    Reiss, P
    Masana, L
    Clotet, B
    [J]. AIDS, 2002, 16 (10) : 1383 - 1389
  • [9] Nunez Marina, 2002, HIV Clin Trials, V3, P186
1